• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problems Improper or Incorrect Procedure or Method (2017); No Apparent Adverse Event (3189)
Patient Problem Insufficient Information (4580)
Event Date 12/17/2023
Event Type  malfunction  
Manufacturer Narrative
D4-(b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : single use; device discarded.
 
Event Description
The consumer reported that their son took a binaxnow covid-19 ag self-test on (b)(6) 2023 but was not aware that the instructions for use were printed on two side of the product insert (pi).As a result of not consulting the entire pi, the consumer indicated that no reagent was added to the test card as required for a valid test.The result of the test showed a negative result and no precautions were taken to avoid covid transmission (masks were not worn and did not quarantine/isolate).The consumer stated that four days later on (b)(6) 2023 that they tested positive for covid-19 and believe that they could have avoided contracting covid-19 if the instructions were printed on one side of the pi so that their son¿s test result would have been accurate.The consumer has a health history of restrictive lung disease, asthma, and bronchitis.No additional patient information, including treatment and outcome, was provided.
 
Manufacturer Narrative
D4-udi:(b)(4).The user added incorrect number (less than 4 drops) of extraction reagent with their binaxnow covid-19 test.This can lead to an unreliable negative result.An unreliable result shall be considered the final determination.In conclusion, abbott diagnostics scarborough did not identify a product deficiency.The batch history record review (bhr) revealed that the product met acceptance criteria for release, and review of complaint trends against the kit lot for the reported issue indicates the product is performing within expected claims in the current revision of the package insert.Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue, however it could have possibly been related to issues including the self-test user performance as the customer didn't consulting the entire pi to complete the test as required and didn't add reagent drops to the test card.Single use; device discarded.
 
Event Description
The consumer reported that their son took a binaxnow covid-19 ag self-test on (b)(6) 2023 but was not aware that the instructions for use were printed on two sides of the product insert (pi).As a result of not consulting the entire pi, the consumer indicated that no reagent was added to the test card as required for a valid test.The result of the test showed a negative result and no precautions were taken to avoid covid transmission (masks were not worn and the user did not quarantine/isolate).The consumer stated that four days later on (b)(6) 2023, they tested positive for covid-19 and believe that they could have avoided contracting covid-19 if the instructions were printed on one side of the pi so that their son¿s test result would have been accurate.The consumer has a health history of restrictive lung disease, asthma, and bronchitis.No additional patient information, including treatment and outcome, was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18502828
MDR Text Key332778104
Report Number1221359-2024-00052
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/04/2024
Device Catalogue Number195-160
Device Lot Number201331
Was Device Available for Evaluation? No
Date Manufacturer Received03/11/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-